AnPac Bio-Medical Science Co., Ltd. announced that Mr. Haohan Xu has been appointed as Co-Chief Executive Officer of the Company. Mr. Xu is the Chief Executive Officer of Apifiny Group Inc., a digital asset trading infrastructure provider based in New York, United States and has been actively engaged in the fintech industry with past directorship and senior executive positions held at fintech companies including Mercurity Fintech Holding Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 USD | +0.99% | -0.85% | -53.93% |
Apr. 22 | Fresh2 Group Receives Nasdaq Notice of Non-Compliance | MT |
Mar. 21 | ADRs Edge Higher; Lufax Climbs Almost 46% | DJ |
1st Jan change | Capi. | |
---|---|---|
-53.93% | 9.02M | |
-28.68% | 9.84B | |
+0.04% | 3.15B | |
+30.38% | 2.99B | |
-14.73% | 2.15B | |
-13.25% | 1.8B | |
+72.47% | 1.49B | |
+23.83% | 770M | |
-2.84% | 762M | |
-22.86% | 575M |
- Stock Market
- Equities
- FRES Stock
- News Fresh2 Group Limited
- AnPac Bio-Medical Science Co., Ltd. Appoints Haohan Xu as Co-Chief Executive Officer